ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin

被引:52
|
作者
Saaber, Friederike [1 ]
Schuetz, Dagmar [1 ]
Miess, Elke [1 ]
Abe, Philipp [1 ]
Desikan, Srinidhi [1 ]
Kumar, Praveen Ashok [1 ]
Balk, Sara [1 ]
Huang, Ke [1 ]
Beaulieu, Jean Martin [2 ]
Schulz, Stefan [1 ]
Stumm, Ralf [1 ]
机构
[1] Jena Univ Hosp, Inst Pharmacol & Toxicol, D-07747 Jena, Germany
[2] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON M5S 1A8, Canada
来源
CELL REPORTS | 2019年 / 26卷 / 06期
关键词
CHEMOKINE RECEPTOR; CORTICAL INTERNEURONS; CXCR4; INTERNALIZATION; MECHANISMS;
D O I
10.1016/j.celrep.2019.01.049
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Phosphorylation of heptahelical receptors is thought to regulate G protein signaling, receptor endocytosis, and non-canonical signaling via recruitment of beta-arrestins. We investigated chemokine receptor functionality under phosphorylation-deficient and beta-arrestin-deficient conditions by studying interneuron migration in the embryonic cortex. This process depends on CXCL12, CXCR4, G protein signaling and on the atypical CXCL12 receptor ACKR3. We found that phosphorylation was crucial, whereas beta-arrestins were dispensable for ACKR3-mediated control of CXCL12 levels in vivo. Cortices of mice expressing phosphorylation-deficient ACKR3 exhibited a major interneuron migration defect, which was accompanied by excessive activation and loss of CXCR4. Cxcl12-overexpressing mice mimicked this phenotype. Excess CXCL12 caused lysosomal CXCR4 degradation, loss of CXCR4 responsiveness, and, ultimately, similar motility defects as Cxcl12 deficiency. By contrast, beta-arrestin deficiency caused only a subtle migration defect mimicked by CXCR4 gain of function. These findings demonstrate that phosphorylation regulates atypical chemokine receptor function without beta-arrestin involvement in chemokine sequestration and non-canonical signaling.
引用
收藏
页码:1473 / +
页数:25
相关论文
共 50 条
  • [41] BMP2 induces osteogenic differentiation through ACKR3 in mesenchymal stem cells
    Liu, Jiang
    Yao, Xin-Tong
    Feng, Xiao-Lei
    Bai, Xi-Zhuang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 664 : 59 - 68
  • [42] ACKR3 Antagonism Enhances the Repair of Demyelinated Lesions Through Both Immunomodulatory and Remyelinating Effects
    Pouzol, Laetitia
    Sassi, Anna
    Tunis, Melanie
    Zurbach, Anais
    Baumlin, Nadege
    Gnerre, Carmela
    Strasser, Daniel S.
    Marrie, Julia
    Vezzali, Enrico
    Martinic, Marianne M.
    NEUROCHEMICAL RESEARCH, 2024, 49 (08) : 2087 - 2104
  • [43] Crosstalk between CXCR4/ACKR3 and EGFR Signaling in Breast Cancer Cells
    Neves, Maria
    Marolda, Viviana
    Mayor, Federico
    Penela, Petronila
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)
  • [44] From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function
    Smit, Martine J.
    van Muijlwijk-Koezen, Jacqueline E.
    MOLECULAR PHARMACOLOGY, 2019, 96 (06) : 735 - 736
  • [45] Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines
    Hanes, Melinda S.
    Salanga, Catherina L.
    Chowdry, Arnab B.
    Comerford, Iain
    McColl, Shaun R.
    Kufareva, Irina
    Handel, Tracy M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (37) : 22385 - 22397
  • [46] Decreased ACKR3 (CXCR7) function causes oculomotor synkinesis in mice and humans
    Whitman, Mary C.
    Miyake, Noriko
    Nguyen, Elaine H.
    Bell, Jessica L.
    Ruiz, Paola M. Matos
    Chan, Wai-Man
    Di Gioia, Silvio Alessandro
    Mukherjee, Nisha
    Barry, Brenda J.
    Bosley, T. M.
    Khan, Arif O.
    Engle, Elizabeth C.
    HUMAN MOLECULAR GENETICS, 2019, 28 (18) : 3113 - 3125
  • [47] Crosstalk between CXCL12/CXCR4/ACKR3 and the STAT3 Pathway
    Ma, Zelong
    Zhou, Faxiao
    Jin, Hua
    Wu, Xiaoming
    CELLS, 2024, 13 (12)
  • [48] Targeted Imaging of the Atypical Chemokine Receptor 3 (ACKR3/CXCR7) in Human Cancer Xenografts
    Azad, Babak Behnam
    Lisok, Ala
    Chatterjee, Samit
    Poirier, John T.
    Pullambhatla, Mrudula
    Luker, Gary D.
    Pomper, Martin G.
    Nimmagadda, Sridhar
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (06) : 981 - 988
  • [49] Deletion of atypical chemokine receptor 3 (ACKR3) increases immune cells at the fetal-maternal interface
    Quinn, Kelsey E.
    Matson, Brooke C.
    Caron, Kathleen M.
    PLACENTA, 2020, 95 : 18 - 25
  • [50] Atypical Chemokine Receptor 3 (ACKR3): A Comprehensive Overview of its Expression and Potential Roles in the Immune System
    Koenen, Joyce
    Bachelerie, Francoise
    Balabanian, Karl
    Schlecht-Louf, Geraldine
    Gallego, Carmen
    MOLECULAR PHARMACOLOGY, 2019, 96 (06) : 809 - 818